These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 16338251

  • 41. Use of secondary preventive medications after the first attack of acute coronary syndrome.
    Salomaa V, Pääkkönen R, Hämäläinen H, Niemi M, Klaukka T.
    Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):386-91. PubMed ID: 17568237
    [Abstract] [Full Text] [Related]

  • 42. Beneficial effects of statin therapy on survival in hypertensive patients with acute myocardial infarction: data from the RICO survey.
    Sicard P, Zeller M, Dentan G, Laurent Y, Touzery C, L'huillier I, Janin-Manificat L, Lorgis L, Beer JC, Makki H, Rochette L, Cottin Y, RICO survey working group.
    Am J Hypertens; 2007 Nov; 20(11):1133-9. PubMed ID: 17954357
    [Abstract] [Full Text] [Related]

  • 43. Absence of sex differences in pharmacotherapy for acute myocardial infarction.
    Jelinski SE, Ghali WA, Parsons GA, Maxwell CJ.
    Can J Cardiol; 2004 Jul; 20(9):899-905. PubMed ID: 15266360
    [Abstract] [Full Text] [Related]

  • 44. Effectiveness and safety of glycoprotein IIb/IIIa inhibitors and clopidogrel alone and in combination in non-ST-segment elevation myocardial infarction (from the National Registry of Myocardial Infarction-4).
    Bromberg-Marin G, Marin-Neto JA, Parsons LS, Canto JG, Rogers WJ, National Registry of Myocardial Infarction-4.
    Am J Cardiol; 2006 Nov 01; 98(9):1125-31. PubMed ID: 17056312
    [Abstract] [Full Text] [Related]

  • 45. Dual renin angiotensin system blockade in patients with acute myocardial infarction and preserved left ventricular systolic function.
    Suşan M, Petrescu L, Riviş AI, Suşan RM, Burghină D, Dan R, Cozma D, Drăgulescu SI.
    Rom J Intern Med; 2005 Nov 01; 43(3-4):187-98. PubMed ID: 16812979
    [Abstract] [Full Text] [Related]

  • 46. Parabolas of medication use and discontinuation after myocardial infarction--are we closing the treatment gap?
    Hudson M, Richard H, Pilote L.
    Pharmacoepidemiol Drug Saf; 2007 Jul 01; 16(7):773-85. PubMed ID: 17486661
    [Abstract] [Full Text] [Related]

  • 47. Clinical benefit of early reperfusion therapy in patients with ST-elevation myocardial infarction usually excluded from randomized clinical trials (results from the Maximal Individual Therapy in Acute Myocardial Infarction Plus [MITRA Plus] registry).
    Koeth O, Zahn R, Gitt AK, Bauer T, Juenger C, Senges J, Zeymer U, Maximal Individual Therapy in Acute Myocardial Infarction Plus Study Group.
    Am J Cardiol; 2009 Oct 15; 104(8):1074-7. PubMed ID: 19801027
    [Abstract] [Full Text] [Related]

  • 48. Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction.
    Halvorsen S, Jortveit J, Hasvold P, Thuresson M, Øie E.
    BMC Cardiovasc Disord; 2016 May 31; 16():115. PubMed ID: 27246583
    [Abstract] [Full Text] [Related]

  • 49. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
    Califf RM, Lokhnygina Y, Velazquez EJ, McMurray JJ, Leimberger JD, Lewis EF, Diaz R, Murin J, Pfeffer MA.
    Am J Cardiol; 2009 Jul 15; 104(2):151-7. PubMed ID: 19576338
    [Abstract] [Full Text] [Related]

  • 50. Pharmacotherapy in patients with stable coronary artery disease treated on an outpatient basis in Poland. Results of the multicentre RECENT study.
    Banasiak W, Wilkins A, Pociupany R, Ponikowski P.
    Kardiol Pol; 2008 Jun 15; 66(6):642-9; discussion 650. PubMed ID: 18626833
    [Abstract] [Full Text] [Related]

  • 51. [Reduction in 28 days and 6 months of acute myocardial infarction mortality from 1995 to 2005. Data from PRIAMHO I, II and MASCARA registries].
    Arós F, Heras M, Vila J, Sanz H, Ferreira-González I, Permanyer-Miralda G, Cuñat J, López-Bescós L, Cabadés A, Loma-Osorio A, Marrugat J, en representación de los investigadores de los registros PRIAMHO I, II y MASCARA.
    Rev Esp Cardiol; 2011 Nov 15; 64(11):972-80. PubMed ID: 21803474
    [Abstract] [Full Text] [Related]

  • 52. Impact of the additive effect of angiotensin-converting enzyme inhibitors and /or statins with antiplatelet medication on mortality after acute ischaemic stroke.
    Hassan Y, Al-Jabi SW, Aziz NA, Looi I, Zyoud SH.
    Basic Clin Pharmacol Toxicol; 2012 Apr 15; 110(4):370-7. PubMed ID: 22023326
    [Abstract] [Full Text] [Related]

  • 53. Effect of early initiation of statins on survival in patients with acute myocardial infarction (the USIC 2000 Registry).
    Ferrières J, Cambou JP, Guéret P, Boutalbi Y, Lablanche JM, Hanania G, Genès N, Cantet C, Danchin N.
    Am J Cardiol; 2005 Feb 15; 95(4):486-9. PubMed ID: 15695134
    [Abstract] [Full Text] [Related]

  • 54. Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction.
    Shore S, Jones PG, Maddox TM, Bradley SM, Stolker JM, Arnold SV, Parashar S, Peterson P, Bhatt DL, Spertus J, Ho PM.
    Heart; 2015 May 15; 101(10):800-7. PubMed ID: 25801001
    [Abstract] [Full Text] [Related]

  • 55. [Changes in the prescription of cardiovascular prevention drugs in France between 1995 and 2003: factors influencing the gap between evidence base medicine and clinical practice].
    Philippe F, Cambou JP, Danchin N, Thomas D.
    Ann Cardiol Angeiol (Paris); 2005 Dec 15; 54 Suppl 1():S30-6. PubMed ID: 16411649
    [Abstract] [Full Text] [Related]

  • 56. Supporting a call to action for peripheral artery disease: insights from two prospective clinical registries.
    Hackam DG, Tan MK, Lin PJ, Mehta PG, Jaffer S, Kates M, Oh M, Grima EA, Langer A, Goodman SG, Vascular Protection Registry, Guideline Oriented Approach in Lipid Lowering Registry Investigators.
    J Vasc Surg; 2006 Oct 15; 44(4):776-81. PubMed ID: 16930931
    [Abstract] [Full Text] [Related]

  • 57. Increasing use of single and combination medical therapy in patients hospitalized for acute myocardial infarction in the 21st century: a multinational perspective.
    Goldberg RJ, Spencer FA, Steg PG, Flather M, Montalescot G, Gurfinkel EP, Kennelly BM, Goodman SG, Dedrick R, Gore JM, Global Registry of Acute Coronary Events Investigators.
    Arch Intern Med; 2007 Sep 10; 167(16):1766-73. PubMed ID: 17846396
    [Abstract] [Full Text] [Related]

  • 58. Secondary prevention following coronary artery bypass grafting has improved but remains sub-optimal: the need for targeted follow-up.
    Turley AJ, Roberts AP, Morley R, Thornley AR, Owens WA, de Belder MA.
    Interact Cardiovasc Thorac Surg; 2008 Apr 10; 7(2):231-4. PubMed ID: 18234766
    [Abstract] [Full Text] [Related]

  • 59. Reduction in sex-based mortality difference with implementation of new cardiology guidelines.
    Novack V, Cutlip DE, Jotkowitz A, Lieberman N, Porath A.
    Am J Med; 2008 Jul 10; 121(7):597-603.e1. PubMed ID: 18538296
    [Abstract] [Full Text] [Related]

  • 60. Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators.
    Pietrasik G, Goldenberg I, McNitt S, Polonsky B, Moss AJ, Zareba W.
    J Cardiovasc Electrophysiol; 2009 Apr 10; 20(4):395-400. PubMed ID: 19017351
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.